Evaluation of Novel Noise Reduction Principles in Hearing Instruments
NCT ID: NCT05582408
Last Updated: 2022-11-17
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
26 participants
INTERVENTIONAL
2022-09-12
2022-11-01
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Assessment of Novel Sound Changing Principles in Hearing Instruments to Determine Their Application - 2019_20
NCT04018911
Assessment of Novel Sound Changing Principles in Hearing Instruments to Determine Their Application - 2018_12
NCT03554577
Assessment of Novel Sound Changing Principles in Hearing Instruments to Determine Their Application - 2020_09
NCT04578457
Exploration of the Functional Effect of Different Hearing Aid Noise Reduction Algorithms in an Ecologically Valid Conversational Situation
NCT06992310
Assessment of Novel Sound Changing Principles in Hearing Instruments to Determine Their Application - 2018_16
NCT03578471
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NON_RANDOMIZED
SINGLE_GROUP
TREATMENT
DOUBLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Hearing Aid Standard NR1
Hearing Aid with standard Noise Reduction (NR1) serves as reference condition.
Measures of Standard Noise Reduction NR1
Each participant will be fitted with the Standard Noise Reduction (NR1)
Novel Noise reduction principles
Noise Reduction Principle NR2 and NR3.
Measures of Noise Reduction Principle NR2
Each participant will be fitted with the novel Noise Reduction principle NR2 on the same hearing aid
Measure of Noise Reduction Principle NR3
Each participant will be fitted with the novel Noise Reduction principle NR3 on the same hearing aid
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Measures of Standard Noise Reduction NR1
Each participant will be fitted with the Standard Noise Reduction (NR1)
Measures of Noise Reduction Principle NR2
Each participant will be fitted with the novel Noise Reduction principle NR2 on the same hearing aid
Measure of Noise Reduction Principle NR3
Each participant will be fitted with the novel Noise Reduction principle NR3 on the same hearing aid
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Written and spoken German,
* Hearing loss range: N3-N4 Hearing loss (sensorineural)
* Healthy outer ear,
* Ability to understand and follow the instruction of the in-vestigator
* Informed consent as documented by signature.
Exclusion Criteria
* Pregnant or breastfeeding women
* Age \>85 years
* known hypersensitivity or allergy,
* limited mobility and not able to attend the appointments
18 Years
85 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Sonova AG
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Marlene Zippel
Role: STUDY_DIRECTOR
Sonova AG
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Hörzentrum Oldenburg gGmbH
Oldenburg, Lower Saxony, Germany
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
SRF-382
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.